1. Table of Contents
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Chronic Liver Disease Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Chronic Liver Disease Clinical Trials by Region
2.2.2 Average Enrollment of Chronic Liver Disease Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Chronic Liver Disease Treatment, 2019

3. Region wise Chronic Liver Disease Clinical Trials
3.1 Asia Pacific Chronic Liver Disease Clinical Trials by Country
3.2 Europe Chronic Liver Disease Clinical Trials by Country
3.3 North America Chronic Liver Disease Clinical Trials by Country
3.4 Middle East and Africa Chronic Liver Disease Clinical Trials by Country
3.5 South and Central America Chronic Liver Disease Clinical Trials by Country

4. Chronic Liver Disease Clinical Trial Trends
4.1 Start Year wise Chronic Liver Disease Clinical Trials
4.2 Phase wise Chronic Liver Disease Clinical Trials
4.3 Trial Status wise Chronic Liver Disease Clinical Trials
4.4 Trial Type wise Chronic Liver Disease Clinical Trials

5. Chronic Liver Disease Average Enrollment Trends
5.1 Average Enrollment in Chronic Liver Disease Trials by Year
5.2 Average Enrollment in Chronic Liver Disease Trials by Phase
5.3 Average Enrollment in Chronic Liver Disease Trials by Status
5.4 Average Enrollment in Chronic Liver Disease Trials by Type of Trial

6. Companies Participating in Chronic Liver Disease Clinical Trials
6.1 Chronic Liver Disease Trials by Sponsor Type
6.2 Chronic Liver Disease Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Chronic Liver Disease Trials- Phase 1
7.2 Chronic Liver Disease Trials- Phase 2
7.3 Chronic Liver Disease Trials- Phase 3
7.4 Chronic Liver Disease Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Chronic Liver Disease Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Chronic Liver Disease Clinical Trials and Enrolment
Figure 5: Europe - Country wise Chronic Liver Disease Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Chronic Liver Disease Clinical Trials and Enrolment
Figure 7: North America - Country wise Chronic Liver Disease Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Chronic Liver Disease Clinical Trials and Enrolment
Figure 9: Chronic Liver Disease Clinical Trials by Phase
Figure 10: Chronic Liver Disease Clinical Trials by Trial Status
Figure 11: Chronic Liver Disease Clinical Trials by Type
Figure 12: Chronic Liver Disease Clinical Trials by Sponsor Type
Figure 13: Chronic Liver Disease Clinical Trials by Leading Sponsors
Figure 14: Chronic Liver Disease Average Enrollment by Phase
Figure 15: Chronic Liver Disease Average Enrollment by Trial Status
Figure 16: Chronic Liver Disease Average Enrollment by Type
Figure 17: Chronic Liver Disease- Average Enrolment by Type of Sponsors
Figure 18: Chronic Liver Disease- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List of Tables
Table 1: Chronic Liver Disease Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Chronic Liver Disease Clinical Trials and Enrolment
Table 5: Europe - Country wise Chronic Liver Disease Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Chronic Liver Disease Clinical Trials and Enrolment
Table 7: North America - Country wise Chronic Liver Disease Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Chronic Liver Disease Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Chronic Liver Disease Average Enrollment by Phase
Table 15: Chronic Liver Disease Average Enrollment by Trial Status
Table 16: Chronic Liver Disease Average Enrollment by Type
Table 17: Chronic Liver Disease- Average Enrolment by Type of Sponsors
Table 18: Chronic Liver Disease- Enrolment by Leading Sponsors

Companies mentioned
Abbott Laboratories, Apex GmbH Internationale Spedition, Eisai Co Ltd, F. Hoffmann-La Roche Ltd, GeneCare Research Institute Co Ltd, GlaxoSmithKline Plc, GRI Bio Inc, PharmaKing Co Ltd, Puma Biotechnology Inc, Shionogi & Co Ltd